Labarre Michael J. Insider Trades

Insider Trading History

Track insider trading activity for Labarre Michael J.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $12.4M 173,856 shares
Last Trade
Feb 27, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$98.9k 1,697 shares
$58.28
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $12.6M 176,053 shares
Last Trade
Feb 26, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$581k 10,000 shares
$58.12
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $13.3M 186,153 shares
Last Trade
Feb 25, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$581k 10,000 shares
$58.06
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $14M 195,453 shares
Last Trade
Feb 23, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$139k 2,410 shares
$57.75
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $1.02M 14,238 shares
Last Trade
Feb 23, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$274k 4,747 shares
$57.75
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $14.2M 197,863 shares
Last Trade
Feb 23, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$274k 4,747 shares
$57.75
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $852k 11,902 shares
Last Trade
Feb 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$684k 11,902 shares
$57.44
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $13.8M 193,116 shares
Last Trade
Feb 16, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$815k 13,988 shares
$58.29
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $12.7M 177,142 shares
Last Trade
Feb 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$197k 3,386 shares
$58.29
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $12.6M 175,838 shares
Last Trade
Feb 15, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$76k 1,304 shares
$58.29
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $0 0 shares
Last Trade
Feb 15, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$197k 3,386 shares
$58.29
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $1.91M 26,608 shares
Last Trade
Oct 16, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$535k 10,000 shares
$53.46
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $13.2M 183,756 shares
Last Trade
Oct 16, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$535k 10,000 shares
$53.46
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $12.4M 173,756 shares
Last Trade
Oct 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$533k 10,000 shares
$53.26
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $2.62M 36,608 shares
Last Trade
Oct 15, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$538k 10,000 shares
$53.82
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $12.4M 173,833 shares
Last Trade
Oct 15, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$537k 10,000 shares
$53.74
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $12.8M 179,265 shares
Last Trade
Oct 15, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$296k 5,509 shares
$53.82
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $12.6M 175,793 shares
Last Trade
Sep 18, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$620k 10,000 shares
$62.03
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $13.2M 183,756 shares
Last Trade
Sep 18, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$623k 10,000 shares
$62.31
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF TECHNICAL OFFICER
Holding Value $849k 11,861 shares
Last Trade
Sep 18, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$623k 10,000 shares
$62.31
$71.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up